Cargando…
Tolerogenic Dendritic Cells Induce Apoptosis-Independent T Cell Hyporesponsiveness of SARS-CoV-2-Specific T Cells in an Antigen-Specific Manner
Although the global pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still ongoing, there are currently no specific and highly efficient drugs for COVID-19 available, particularly in severe cases. Recent findings demonstrate that severe COVID-19 disease th...
Autores principales: | Van Delen, Mats, Janssens, Ibo, Dams, Amber, Roosens, Laurence, Ogunjimi, Benson, Berneman, Zwi N., Derdelinckx, Judith, Cools, Nathalie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740551/ https://www.ncbi.nlm.nih.gov/pubmed/36499533 http://dx.doi.org/10.3390/ijms232315201 |
Ejemplares similares
-
Immunomodulatory Effects of 1,25-Dihydroxyvitamin D(3) on Dendritic Cells Promote Induction of T Cell Hyporesponsiveness to Myelin-Derived Antigens
por: Lee, Wai-Ping, et al.
Publicado: (2016) -
Shuttling Tolerogenic Dendritic Cells across the Blood–Brain Barrier In Vitro via the Introduction of De Novo C–C Chemokine Receptor 5 Expression Using Messenger RNA Electroporation
por: De Laere, Maxime, et al.
Publicado: (2018) -
Antigen-Specific Treatment Modalities in MS: The Past, the Present, and the Future
por: Derdelinckx, Judith, et al.
Publicado: (2021) -
Transmigration across a Steady-State Blood–Brain Barrie Induces Activation of Circulating Dendritic Cells Partly Mediated by Actin Cytoskeletal Reorganization
por: Meena, Megha, et al.
Publicado: (2021) -
Cryopreserved vitamin D(3)-tolerogenic dendritic cells pulsed with autoantigens as a potential therapy for multiple sclerosis patients
por: Mansilla, María José, et al.
Publicado: (2016)